Please try another search
Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry, and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.
Name | Age | Since | Title |
---|---|---|---|
Pengfei Deng | 36 | 2018 | Non-Employee Representative Supervisor |
Ying Wang | 57 | 2018 | Chairman of the Board |
Mingxu Yuan | 51 | 2018 | GM & Director |
Xiaoyan Wu | 51 | 2018 | Employee Representative Supervisor |
Jiayu Zhu | 43 | 2018 | Chairman of the Supervisory Board |
Fang Fang | 41 | 2020 | Independent Director |
Lei Zhao | 52 | 2022 | Director |
Shu Shang | 44 | 2018 | Independent Director |
Hongwu Geng | 55 | 2021 | Director |
Daming Zhang | 51 | 2018 | Deputy GM & Director |
Zenggui Chen | 53 | 2021 | Deputy MG & Director |
Jin Li | 58 | 2018 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review